Tarsier Pharma (TARX)

Currency in USD
0.00
0.00(0.00%)
Closed·
TARX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.000.00
52 wk Range
0.000.00
Key Statistics
Prev. Close
-
Open
-
Day's Range
-
52 wk Range
0-0
Volume
-
Average Volume (3m)
-
1-Year Change
0%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TARX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Currently not supported.

Tarsier Pharma News & Analysis

Show more
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Mar 31, 2026
EPS / Forecast
-1.73 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

TARX Income Statement

Compare TARX to Peers and Sector

Metrics to compare
TARX
Peers
Sector
Relationship
P/E Ratio
UnlockNaNNaNUnlock
PEG Ratio
UnlockNaNNaNUnlock
Price/Book
UnlockNaNNaNUnlock
Price / LTM Sales
UnlockNaNNaNUnlock
Upside (Analyst Target)
UnlockNaNNaNUnlock
Fair Value Upside
UnlockNaNNaNUnlock

Tarsier Pharma Ltd. operates as a clinical stage biopharmaceutical company in Israel. The company engages in the development and commercialization of novel pharmaceutical therapies for the treatment of ocular diseases with underlying inflammatory pathologies. The company’s dazdotuftide platform technology is a bio -inspired immunomodulator designed to treat blinding inflammatory ocular diseases and is currently being developed as both eye drops and intravitreal injections. Its product candidate, TRS01 is an eye drop formulation of dazdotuftide, a new chemical entity developed for the treatment of non -infectious anterior uveitis including patients diagnosed with glaucoma. Additionally, the company engages in the pre-clinical development of an intravitreal slow-release injection formulation of dazdotuftide known as TRS02 for the treatment of back-of-the-eye retinal diseases, such as DME, NPDR, dry-AMD and back-of-the-eye uveitis. The company was formerly known as Tarsius Pharma Ltd. and changed its name to Tarsier Pharma Ltd. in February 2021. Tarsier Pharma Ltd. was incorporated in 2016 and is based in Zihron Ya'akov, Israel.

Industry
-
Sector
-
Employees
4

FAQ

What Is the Tarsier Pharma (TARX) Stock Price Today?

The Tarsier Pharma stock price today is 0.00 USD.

What Stock Exchange Does Tarsier Pharma Trade On?

Tarsier Pharma is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for Tarsier Pharma?

The stock symbol for Tarsier Pharma is "TARX."

What Is the Tarsier Pharma Market Cap?

As of today, Tarsier Pharma market cap is 0.00 USD.

What Is Tarsier Pharma's Earnings Per Share (TTM)?

The Tarsier Pharma EPS (TTM) is -2.26.

From a Technical Analysis Perspective, Is TARX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Tarsier Pharma Stock Split?

Tarsier Pharma has split 0 times.

How Many Employees Does Tarsier Pharma Have?

Tarsier Pharma has 4 employees.

What is the current trading status of Tarsier Pharma (TARX)?

As of Jul 05, 2026, Tarsier Pharma (TARX) is trading at a price of 0.00 USD, with a previous close of 0.00 USD. The stock has fluctuated within a day range of 0.00 USD to 0.00 USD, while its 52-week range spans from 0.00 USD to 0.00 USD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.